(Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | -587.8K | -1.79M | -924.15K |
Net income from continuing operations | ---1.03M | ---2.48M | ---6.31M |
Operating gains losses | ---445 | --2.77K | --3.39K |
Depreciation and amortization | --880 | --625 | ---- |
Unrealized gains and losses of investment securities | --9K | --46.03K | ---- |
Remuneration paid in stock | --98.4K | --1.58M | ---- |
Other non cashItems | ---- | ---- | --3.68M |
Change In working capital | --104.13K | ---942.9K | --1.7M |
-Change in receivables | ---37.9K | ---159.45K | ---140.77K |
-Change in prepaid assets | --20.52K | ---252.18K | ---270K |
-Change in payables and accrued expense | --121.51K | ---531.27K | --2.11M |
Cash from discontinued investing activities | |||
Operating cash flow | ---587.8K | ---1.79M | ---924.15K |
Investing cash flow | |||
Cash flow from continuing investing activities | -33.26K | -412.64K | 2.16M |
Net PPE purchase and sale | ---1 | ---17.61K | ---- |
Net business purchase and sale | ---- | ---- | --2.16M |
Net investment purchase and sale | ---33.26K | ---395.03K | ---- |
Cash from discontinued investing activities | |||
Investing cash flow | ---33.26K | ---412.64K | --2.16M |
Financing cash flow | |||
Cash flow from continuing financing activities | 2.53M | ||
Net common stock issuance | ---- | ---- | --3.09M |
Net other financing activities | ---- | ---- | ---555.65K |
Cash from discontinued financing activities | |||
Financing cash flow | ---- | ---- | --2.53M |
Net cash flow | |||
Beginning cash position | --1.57M | --3.77M | --0 |
Current changes in cash | ---621.06K | ---2.21M | --3.77M |
End cash Position | --945.36K | --1.57M | --3.77M |
Free cash from | ---587.8K | ---1.81M | ---924.15K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.